Study: GLP-1 drugs may slow biological aging

A new University of California study suggests that popular GLP-1 drugs used to treat obesity and diabetes may slow biological aging in the body. The results point to potential effects beyond weight loss and blood sugar regulation. The study is preliminary and requires further clinical research.